Evaluate a Treatment Adapted to the PET Response Compared to a Standard Treatment, for Low Risk DLBCL CD 20+ Patients
Clinical trial NCT01285765 · COMPLETED
Trial details
- NCT number
- NCT01285765
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2020-05-23
- Enrollment
- 650
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.